Skip to main content
Erschienen in: Wiener klinische Wochenschrift 3-4/2022

Open Access 16.09.2021 | original article

Underweight but not overweight is associated with excess mortality in septic ICU patients

verfasst von: Thomas Danninger, M.D., Richard Rezar, M.D., Behrooz Mamandipoor, M.Sc., Daniel Dankl, M.D., Andreas Koköfer, M.D., Christian Jung, M.D., Ph.D., Bernhard Wernly, M.D., Ph.D., Venet Osmani, Ph.D.

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2022

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Summary

Background

Higher survival has been shown for overweight septic patients compared with normal or underweight patients in the past. This study aimed at investigating the management and outcome of septic ICU patients in different body mass index (BMI) categories in a large multicenter database.

Methods

In total, 16,612 patients of the eICU collaborative research database were included. Baseline characteristics and data on organ support were documented. Multilevel logistic regression analysis was performed to fit three sequential regression models for the binary primary outcome (ICU mortality) to evaluate the impact of the BMI categories: underweight (<18.5 kg/m2), normal weight (18.5 to < 25 kg/m2), overweight (25 to < 30 kg/m2) and obesity (≥ 30 kg/m2). Data were adjusted for patient level characteristics (model 2) as well as management strategies (model 3).

Results

Management strategies were similar across BMI categories. Underweight patients evidenced higher rates of ICU mortality. This finding persisted after adjusting in model 2 (aOR 1.54, 95% CI 1.15–2.06; p = 0.004) and model 3 (aOR 1.57, 95%CI 1.16–2.12; p = 0.003). No differences were found regarding ICU mortality between normal and overweight patients (aOR 0.93, 95%CI 0.81–1.06; p = 0.29). Obese patients evidenced a lower risk of ICU mortality compared to normal weight, a finding which persisted across all models (model 2: aOR 0.83, 95%CI 0.69–0.99; p = 0.04; model 3: aOR 0.82, 95%CI 0.68–0.98; p = 0.03). The protective effect of obesity and the negative effect of underweight were significant in individuals > 65 years only.

Conclusion

In this cohort, underweight was associated with a worse outcome, whereas obese patients evidenced lower mortality. Our analysis thus supports the thesis of the obesity paradox.
Hinweise
The authors Thomas Danninger, Richard Rezar, Bernhard Wernly and Venet Osmani contributed equally to the manuscript.
Availability of data and material: All data relevant for this study will be given by the authors upon specific request. Patients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of the research.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Both overfeeding and undernourishment are highly relevant challenges for public healthcare systems worldwide [1]. Obesity is known to be associated with low-grade chronic inflammation and cardiometabolic diseases [2]. It also goes hand in hand with a higher risk for infections and sepsis, which is another common clinical challenge associated with high morbidity and mortality [35]. A better understanding of subgroups at higher risk could therefore contribute to improved patient care [611]. The pathogenesis and optimal treatment of septic patients is the subject of intensive research, whereas mortality remains high and an often limited functional capacity in surviving patients remains a challenge [6, 1214]. Underweight is a less common problem than overweight in Western societies. Yet, the relationship between sepsis and underweight is of great interest from a clinical perspective as undernourished septic patients have been consistently observed to suffer from excess mortality [1517]. On the contrary, the association of sepsis with obesity is complex. While adipose patients have a higher incidence of sepsis, an obesity paradox was observed by different authors [5, 1820]. This refers to the phenomenon that adipose septic patients, contrary to the experience with many other (chronic) diseases, have a better survival rate than normal or underweight patients [21]. The phenomenon that obesity is a risk factor for the occurrence of a critical illness on the one hand but acutely ill obese patients have a better outcome on the other hand, has also been observed in other clinical situations and remains subject of current debate [22]. Since data on the relationship between obesity and sepsis in particular are contradictory and often based on single center studies, we wanted to investigate the relationship between body mass index (BMI) and mortality in septic patients in a large, multicenter database. The aim of our paper was to evaluate possible associations of overweight and underweight with the outcome of septic patients. We conducted this analysis in the large-scale eICU collaborative research database [23].

Methods

Study subjects

The eICU collaborative research database is a multicenter ICU database, including over 200,000 admissions on 335 ICUs from 208 hospitals across the USA in 2014 and 2015 [23]. We extracted baseline characteristics and organ support data (use of vasopressors and mechanical ventilation) on day one. The database is released under the Health Insurance Portability and Accountability Act (HIPAA) safe harbor provision. Septic patients in this study were identified via the method established by Pollard et al. [23]. Elixhauser Comorbidity Index was calculated using the Agency for Healthcare Research and Quality (AHRQ) method [24, 25].

Statistical analysis

We expressed continuous data points as median ± interquartile range and assessed differences between independent groups using Kruskal-Wallis equality of populations rank test accordingly. Categorical data are expressed as numbers (percentage), χ2-test was used to calculate univariate differences between groups. The primary exposure was BMI as an ordinal variable based on the World Health Organization BMI classification: underweight (BMI < 18.5 kg/m2), normal weight (BMI 18.5 to < 25 kg/m2), overweight (BMI 25 to < 30 kg/m2) and obesity (BMI ≥ 30 kg/m2). The primary outcome was ICU mortality. The secondary outcomes were management strategies, mechanical ventilation, and vasopressor use. We used multilevel logistic regression to fit three sequential regression models for the binary primary outcome to evaluate the impact of the BMI category on ICU mortality. First, a baseline model with the BMI category as a fixed effect and ICU as random effect (model 1) was fitted. Second, to model 1, patient characteristics (age, sequential organ failure assessment, SOFA, score, sex, infection source, ethnics, model 2) were added as independent variables to the model. Third, to model 2, management strategies (model 3) were added to the model. Model 1 and model 2 were used to evaluate the primary and secondary outcomes, whereas model 3 was only used to assess the primary outcomes. We chose the independent variables based on our clinical experience. We calculated adjusted odds ratios (aOR) with respective 95% confidence intervals (95% CI). Additionally, we performed sensitivity analyses, stratifying patients with received fluids > 30 ml/kg/h, creatinine above and below 2.0 mg/dL (arbitrary cut-off), lactate above and below 2.0 mmol/L (arbitrary cut-off), age above and below 65 years (arbitrary cut-off), and SOFA score above and below 10 points (arbitrary cut-off), with and without mechanical ventilation, with and without vasopressor use, and patients with a primary pulmonary focus versus non-pulmonary/all other foci. We performed the stratified sensitivity analyses using model 1. All tests were two-sided, and a p-value of < 0.05 was considered statistically significant. Stata/IC 16.1 (StataCorp LLC 2019. Stata Statistical Software: Release 16. College Station, TX, USA) was used for all statistical analyses.

Results

In total, 16,612 septic patients were included in this analysis, whereas 964 (6%) patients were underweight, 5219 (31%) were of normal weight, 4402 (26%) were overweight and 6027 (36%) were obese. The baseline characteristics are shown in Tables 1 and 2. Obese patients tended to be younger (64 + 19 years vs. 68 + 23 years; p = 0.001) but had SOFA scores >10 (14% vs. 12%; p < 0.001) more often; however, the most likely clinically relevant differences between the groups were the higher rates of lactate concentrations above 2.0 mmol/L in underweight patients (47% in underweight vs. 44% in normal weight patients) and the higher rates of creatinine concentrations > 2.0 mg/dL in obese patients (36% in obese patients vs. 22% in normal weight patients). Also, we found a significant trend towards higher Elixhauser comorbidity indices in underweight patients compared to all other BMI classes (see Table 1).
Table 1
Baseline characteristics in the total cohort stratified for BMI categories
Characteristic
Underweight
Normal weight
Overweight
Obesity
p-value
 
n = 964
n = 5219
n = 4402
n = 6027
 
Anthropometric data
BMI in kg/m2, median (IQR)
17 (2)
23 (3)
27 (2)
36 (9)
< 0.001*
Age in years, median (IQR)
66 (24)
68 (23)
68 (21)
64 (19)
< 0.001*
Age > 65 years, n (%)
489 (51)
2,925 (56)
2479 (56)
2814 (47)
< 0.001*
Elixhauser Comorbidity Index, median (IQR)
3 (10)
0 (10)
0 (10)
0 (9)
0.003*
Risk parameter
SOFA score points, median (IQR)
5 (5)
6 (5)
5 (5)
6 (6)
0.004*
SOFA score > 10 points, n (%)
106 (11)
638 (12)
573 (13)
861 (14)
0.002*
Heart rate > 110 bpm, n (%)
283 (31)
1347 (27)
1145 (28)
1368 (25)
< 0.001*
Body temperature > 38 °C, n (%)
87 (10)
500 (10)
516 (12)
769 (13)
< 0.001*
Biomarkers
Creatinine mg/dL, median (IQR)
1.0 (1.2)
1.1 (1.3)
1.3 (1.4)
1.5 (1.6)
< 0.001*
Creatinine > 2.0 mg/dL, n (%)
193 (22)
1226 (25)
1196 (29)
2035 (36)
< 0.001*
Lactate mmol/L, median (IQR)
1.9 (2.2)
1.8 (1.9)
1.8 (1.8)
1.8 (1.8)
0.12
Lactate > 2.0 mmol/L, n (%)
255 (47)
1358 (44)
1135 (43)
1530 (42)
0.14
Length of stay in h
< 0.001*
< 72 h, n (%)
610 (63)
3304 (63)
2790 (63)
3657 (61)
72–168 h, n (%)
257 (27)
1255 (24)
1065 (24)
1524 (25)
> 168 h, n (%)
97 (10)
660 (13)
547 (12)
846 (14)
Fluid management in first 24 h
Total amount of fluids in ml, median (IQR)
2730 (3316)
2725 (2885)
2684 (2896)
2673 (2881)
< 0.001*
Amount of fluid per kg bodyweight in ml, median (IQR)
57 (67)
43 (47)
34 (37)
25 (30)
< 0.001*
Amount of fluid per kg BW > 30 ml/kg/h, n (%)
322 (71)
1700 (65)
1235 (57)
1253 (42)
< 0.001*
BMI body mass index, BW body weight, GI gastrointestinal, IQR interquartile range, SOFA sepsis-related organ failure assessment
* statistically significant
Table 2
Baseline characteristics in the total cohort stratified for BMI categories
Characteristic
Underweight
Normal weight
Overweight
Obesity
p-value
 
n = 964, n (%)
n = 5219, n (%)
n = 4402, n (%)
n = 6027, n (%)
 
Infectious focus
UTI
179 (19)
1,162 (22)
1,019 (23)
1,490 (25)
< 0.001*
Pulmonary
455 (47)
2,138 (41)
1,600 (36)
2,035 (34)
< 0.001*
GI
97 (10)
689 (13)
603 (14)
657 (11)
< 0.001*
Cutaneous
56 (6)
320 (6)
320 (7)
718 (12)
< 0.001*
Unknown
112 (12)
564 (11)
536 (12)
720 (12)
0.15
Other
62 (6)
337 (7)
308 (7)
384 (6)
0.61
Gynecologic
3 (< 1)
9 (< 1)
16 (< 1)
23 (< 1)
0.20
Ethnicity
European
720 (75)
4,013 (77)
3,387 (77)
4,816 (80)
< 0.001*
African American
142 (15)
552 (11)
434 (10)
616 (10)
< 0.001*
Hispanic
35 (4)
223 (4)
197 (5)
185 (3)
0.001*
Asian
17 (2)
105 (2)
82 (2)
50 (< 1)
< 0.001*
Native American
8 (< 1)
32 (< 1)
36 (< 1)
63 (< 1)
0.10
Other
42 (4)
294 (6)
266 (6)
297 (5)
0.03*
BMI body mass index; GI gastrointestinal; UTI urinary tract infection
* statistically significant
The amount of administered i.v. fluid per kg bodyweight was highest in underweight patients and lowest in obese patients (see Table 1; p < 0.001). The rates of patients receiving fluids > 30 ml/kg/h in the first 24 h was higher in underweight compared to normal weight and obese patients (72% vs. 65% vs. 42%; p < 0.001). We also observed differences in length of stay, with obese patients evidencing the lowest rate of short-term (< 72 h) stays (61% vs. 63% in normal weight patients). The management strategies with respect to vasopressor use and mechanical ventilation were similar across all BMI categories (see Tables 3 and 4 and 5).
Table 3
Associations of underweight versus normal weight patients with mortality and management strategies in three multilevel logistic regression models
 
Crude events
   
Characteristic
Normal weight
Underweight
Model 1a
Model 2b
Model 3c
 
n (%)
n (%)
aOR (95% CI, p-value)
aOR (95% CI, p-value)
aOR (95% CI, p-value)
ICU mortality
553 (11)
134 (14)
1.38 (1.12–1.70, 0.002)
1.54 (1.15–2.06, 0.004)
1.57 (1.16–2.12, 0.003)
Management
Mechanical ventilation
1175 (23)
221 (23)
1.05 (0.88–1.25, 0.58)
0.83 (0.64–1.08, 0.17)
Vasopressor use
1708 (33)
291 (30)
0.87 (0.74–1.02, 0.08)
1.03 (0.82–1.30, 0.80)
aOR adjusted odds ratio, BMI body mass index, CI confidence interval, ICU intensive care unit, SOFA sepsis-related organ failure assessment
aModel 1: ICU cluster as random effect
bModel 2: Model 1 plus patient level (age, creatinine concentration, ethnics, heart rate, infection focus, lactate concentration, sex, SOFA score)
cModel 3: Model 2 plus management strategies (mechanical ventilation, vasopressor use)
Table 4
Associations of overweight versus normal weight patients with mortality and management strategies in three multilevel logistic regression models
 
Crude events
   
Characteristic
Normal weight
Overweight
Model 1a
Model 2b
Model 3c
 
n (%)
n (%)
aOR (95%CI, p-value)
aOR (95%CI, p-value)
aOR (95%CI, p-value)
ICU mortality
553 (11)
437 (10)
0.93 (0.81–1.06, 0.29)
0.88 (0.73–1.05, 0.16)
0.88 (0.73–1.06, 0.18)
Management
Mechanical ventilation
1175 (23)
935 (21)
0.93 (0.84–1.03, 0.14)
0.96 (0.83–1.11, 0.58)
Vasopressor use
1708 (33)
1431 (33)
0.99 (0.90–1.08, 0.79)
0.94 (0.83–1.08, 0.40)
aOR adjusted odds ratio, BMI body mass index, CI confidence interval, ICU intensive care unit, SOFA Sepsis-related organ failure assessment
aModel 1: ICU cluster as random effect
bModel 2: Model 1 plus patient level (age, creatinine concentration, ethnics, heart rate, infection focus, lactate concentration, sex, SOFA score)
cModel 3: Model 2 plus management strategies (mechanical ventilation, vasopressor use)
Table 5
Associations of obese versus normal weight patients with mortality and management strategies in three multilevel logistic regression models
 
Crude events
   
Characteristic
Normal weight
Obese
Model 1a
Model 2b
Model 3c
 
n (%)
n (%)
aOR (95% CI, p-value)
aOR (95% CI, p-value)
aOR (95% CI, p-value)
ICU mortality
553 (11)
552 (9)
0.85 (0.74–0.96, 0.009)
0.83 (0.69–0.99, 0.04)
0.82 (0.68–0.98, 0.03)
Management
Mechanical ventilation
1175 (23)
1441 (24)
1.08 (0.98–1.89, 0.11)
1.14 (0.99–1.32, 0.06)
Vasopressor use
1708 (33)
1977 (33)
0.996 (0.913–1.086, 0.93)
0.97 (0.86–1.10, 0.62)
aOR adjusted odds ratio, BMI body mass index, CI confidence interval, ICU intensive care unit, SOFA Sepsis-related organ failure assessment
aModel 1: ICU cluster as random effect
bModel 2: Model 1 plus patient level (age, creatinine concentration, ethnics, heart rate, infection focus, lactate concentration, sex, SOFA score)
cModel 3: Model 2 plus management strategies (mechanical ventilation, vasopressor use)
Underweight patients evidenced higher rates of ICU mortality (14% vs. 11%; p = 0.002), and this finding persisted after adjusting for both patient level characteristics in model 2 as well as in model 3. We did not find differences regarding ICU mortality between normal weight and overweight patients (11% vs. 10%; see Table 4). Obese patients evidenced a lower risk of ICU mortality (9% vs. 11%; p < 0.001) compared to normal weight, a finding which persisted after adjustment in all three models (see Table 5).
In the stratified analyses for underweight versus normal weight patients, we found a higher risk for ICU mortality in underweight patients above 65 years (aOR 1.52, 95% CI 1.17–1.99), initial lactate concentration above 2.0 mmol/L (aOR 1.41, 95%CI 1.03–1.93), those without vasopressor use (aOR 1.64, 95% CI 1.22–2.22), mechanical ventilation (aOR 1.48, 95% CI 1.12–1.94), initial creatinine < 2.0 mg/dL (aOR 1.54, 95% CI 1.18–2.01), SOFA score < 10 points (aOR 1.48, 95% CI 1.15–1.90), heart rate above 110 bpm (aOR 1.86, 95% CI 1.33–2.59), and those with a pulmonary focus (aOR 1.38, 95% CI 1.04–1.84). The corresponding Forest plot is given in Fig. 1.
In the stratified analyses for overweight versus normal weight patients, we found no differences in the odds of ICU mortality. The corresponding Forest plot is given in Fig. 2. In the stratified analyses for obese versus normal weight patients, we found lower odds of ICU mortality in obese patients in the subgroup of patients aged > 65 years (aOR 0.77, 95% CI 0.65–0.91), patients without vasopressor use (aOR 0.78, 95% CI 0.63–0.96), without mechanical ventilation (aOR 0.77, 95% CI 0.65–0.92), initial creatinine below 2.0 mg/dL (aOR 0.74, 95% CI 0.62–0.89), SOFA score below 10 points (aOR 0.68, 95% CI 0.58–0.81) and heart rate below 110 bpm (aOR 0.82, 95% CI 0.70–0.96). The corresponding Forest plot is given in Fig. 3.

Discussion

In this study we could not find any differences regarding the use of organ replacement treatment in septic patients with different BMI classes; however, the amount of administered fluid relative to body weight was significantly higher in underweight patients than in normal or overweight individuals. Furthermore, we found an excess mortality of underweight patients, while obese patients showed higher survival rates. These findings could be demonstrated in univariate analysis as well as after extensive adjustment for clinically relevant confounders and were particularly relevant for individuals > 65 years of age. To what extent different fluid management or other factors contributed to the observed robust association of underweight and excess mortality cannot be answered by this study.
The results of our analysis support the thesis of an obesity paradox in septic patients, indicating that obese patients do show higher survival rates compared to normal weight individuals. Similar results were recently shown by Li et al. in another large (n = 5563) single center US-based dataset [26]. They could show that not only short-term but also longer-term survival was higher in obese septic patients [26]. This so-called obesity paradox, initially unexpected from the perspective of the clinician (who is used to associate obesity with a higher risk of disease), was also suggested by previous meta-analyses of septic patients stratified for weight classes [20, 27]. It has also been described in patients with acute coronary syndrome or acute respiratory distress syndrome [28, 29]. On the other hand, Jagan et al. were able to show that the effect of BMI on mortality of septic patients in a cohort of 7967 patients was no longer detectable after adjustment for the severity of the acute disease (using acute physiology and chronic health evaluation III score) [30]. In our analysis, however, the effect remained detectable even after extensive adjustment.
The pathophysiological correlate of this observed obesity paradox is beyond the scope of this manuscript, and we can only speculate. A higher BMI was shown to be associated with higher levels of anti-inflammatory interleukins, which could ameliorate the excessive immune reaction, which is typical for sepsis [31]. Also, lipoproteins were shown to have a beneficial effect by binding lipid pathogens and sequestration of lipopolysaccharides (LPS) via (very) low-density lipoprotein receptors [32, 33]; however, other authors have not been able to prove a connection between BMI and the concentrations of cytokines in healthy volunteers [34]. Preclinical basic scientific data on the obesity paradox are also inconsistent [35]. The obesity paradox could have other reasons besides an altered cytokine response [36]. For example, the greater energy storage capacity of obese patients could be beneficial in acute consuming diseases, such as sepsis. Other authors have postulated that the effects of adipose tissue on the renin-angiotensin balance could contribute to better outcomes in obese patients [36, 37].
Nevertheless, despite the relatively robust data, one should remember that the available studies are primarily observational, and thus conclusions on causalities should only be drawn to a limited extent. The premise of the obesity paradox (namely that clinicians associate obesity with higher risk) could contribute to this effect: more obese patients could receive intensive care earlier, be treated more aggressively, and receive more intensive care from nursing staff [38]. Also, the observed effect could be primarily limited to overdominant subgroups, such as older patients, as the patients in many studies had a relatively high average age [19]. This consideration is also supported by our analysis: The protective effect of obesity was only detectable in the subgroup of older patients (> 65 years)—perhaps in this subgroup obesity is an epiphenomenon for e.g. the absence of frailty (which is known to be associated with adverse outcomes), and the possible cardiometabolic risks of obesity are therefore less relevant [39, 40]. On the other hand, these considerations remain speculative in any case, and in our analysis obesity in younger patients was not associated with excess mortality either.
In addition to higher survival rates in obese patients, we have demonstrated excess mortality in underweight patients. This effect is also in line with previous studies on this topic. Zhou et al. were recently able to show that a lower BMI was associated with worse outcome in patients with sepsis [17]. In contrast, a higher incidence of sepsis has been shown for overweight people in a study analyzing over 400,000 individuals [41]. Underweight was shown to be a risk factor in other conditions or after cardiac procedures [42]. As with obesity, the exact causality of the observed association between underweight and the mortality of septic patients is unclear. In contrast to the excess of protective factors in obese patients, it is logical to assume that due to the lack of adipose tissue, and therefore lower binding capacity of pathogenic lipids and LPS mentioned above in the text, underweight patients suffer from a higher mortality in sepsis. It is also known that underweight patients not only have a lean body mass but are frequently undersupplied with essential nutrients, like vitamins and trace elements, usually have less musculature (especially in the old, where it may indicate frailty), can suffer from underweight due to chronic diseases or addiction and often have a lower socioeconomic status [43]. This is also reflected in our work by the significant difference regarding Elixhauser comorbidity indices. The Elixhauser comorbidity index has been validated in its different versions by various authors in the past, controls for comorbidities not directly related to the admission diagnosis, and correlates well with in-hospital mortality. It is a useful marker to summarize multiple pre-existing conditions and to estimate pre-existing morbidity [44]. Furthermore, ethnic factors certainly play a role, as in our study a higher proportion of individuals with European ethnicity was found in obese patients, whereas more Asian patients were observed in the underweight group. Ethnical differences in body tissue composition are well known [45].
An important point would be to provide functional assessments in ICU databases in addition to common intensive care scores in the future. For example, in addition to baseline data such as BMI, it would be important to perform a functional assessment for activities of daily life (ADL, e.g. by Katz index), but also with respect to nutritional status (e.g., by mini nutritional status) and to analyze data accordingly. In the future, this could help to clarify the debate regarding the optimal BMI, since old people are often identified as undernourished despite a normal BMI [46]. Another important point is that this study relies on data from the USA and thus may not be equally applicable to all other countries. For example, the USA remains the high-income country with the highest average BMI, although various countries around the globe follow this trend and Europe also struggles with obesity as a major health challenge [47]. Nevertheless, there are two other important points to consider here: as mentioned earlier, BMI alone is probably not sufficient to fully illuminate the issue, as nutritional status certainly plays a relevant role and here also differences between different countries exist. Another limitation for outcome analyses between distinct countries with currently available databases are different definitions of sepsis and septic shock. In the future, more accurate statements should be possible with newer databases that use the current sepsis‑3 definition [47].
Ward et al. recently demonstrated that suboptimal fluid management could also contribute to this effect, especially in underweight patients [15]. In our study we could detect significant differences in the fluid management of septic patients in the different BMI classes. In the stratified analysis, the excess mortality of underweight patients was also detectable, especially in those patients who received > 30 ml/kg/h of fluids in the first 24 h. On the other hand, the amount of fluid, even in relation to body weight, can only be assessed to a limited extent in isolation from the specific clinical situation. The cut-off of 30 ml/kg/24h is also controversial [48]. In addition, however, the greatest limitation in this respect is the high number of missing values (n = 8276) in this variable. We have deliberately decided against imputations, since our clinical experience shows that fluid management is handled very individually. Our finding that underweight patients have excess mortality and also receive a high relative amount of fluid therefore remains descriptive.
We hope that our exploratory analysis of nearly 16,000 septic patients will motivate clinicians to pay special attention to the counterintuitive high-risk group of underweight patients with sepsis. We also hope that our results will help the scientific community to design prospective studies that will shed more light on the impact of BMI in septic patients and optimal fluid management.

Limitations

This is a retrospective analysis or a dataset which was not a priori set up to investigate the present research question, and our results are therefore limited to thesis-generating character. Although we fitted several regression models and adjusted them for various potential confounding factors, we cannot rule out the possibility that other aspects that may not be included in the data set may ultimately influence the outcome. As discussed above, obese patients might be admitted to critical care earlier compared to other patients, and we cannot adjust for this potential selection bias. Another limitation of our analysis is the lack of long-term data or functional outcomes of the patients. This also limits an analysis regarding the ideal body weight in terms of outcome, as probably functional and nutritional status would be relevant confounders here. Also, data on patient management are not available in greatest detail. We have already commented on the high number of missing values in the data on fluid substitution. We would like to emphasize again that this could lead to a selection bias. Finally, the low mortality in relation to other studies must be stated as a limitation. We have selected the patients using an established method and also observed similar results in the sensitivity analyses for patients with shock (increased lactate, need for vasoactive substances, high SOFA score).

Conclusion

In this cohort, underweight (BMI < 18.5 kg/m2) was associated with a higher mortality in septic patients, whereas a better outcome was observed in obese patients. Our analysis thus supports the thesis of the obesity paradox, and also indicates that in older individuals (> 65 years) BMI could be a surrogate parameter for frailty, as in that age group significant differences regarding outcome were shown. To what extent different fluid management strategies or other factors contributed to the observed robust association of underweight and excess mortality cannot be answered by means of this study.

Funding

No (industry) sponsorship has been received for this investigator-initiated study.

Conflict of interest

T. Danninger, R. Rezar, B. Mamandipoor, D. Dankl, A. Koköfer, C. Jung, B. Wernly and V. Osmani declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Literatur
1.
Zurück zum Zitat McLellan F. Obesity rising to alarming levels around the world. Lancet. 2002;359(9315):1412.PubMed McLellan F. Obesity rising to alarming levels around the world. Lancet. 2002;359(9315):1412.PubMed
2.
Zurück zum Zitat Festa A, D’Agostino R Jr., Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25(10):1407–15.PubMed Festa A, D’Agostino R Jr., Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25(10):1407–15.PubMed
3.
Zurück zum Zitat Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.PubMed Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.PubMed
4.
Zurück zum Zitat Ghilotti F, Bellocco R, Ye W, Adami HO, Trolle Lagerros Y. Obesity and risk of infections: results from men and women in the Swedish National March Cohort. Int J Epidemiol. 2019;48(6):1783–94.PubMed Ghilotti F, Bellocco R, Ye W, Adami HO, Trolle Lagerros Y. Obesity and risk of infections: results from men and women in the Swedish National March Cohort. Int J Epidemiol. 2019;48(6):1783–94.PubMed
5.
Zurück zum Zitat Wang HE, Griffin R, Judd S, Shapiro NI, Safford MM. Obesity and risk of sepsis: a population-based cohort study. Obesity (Silver Spring). 2013;21(12):E762–E9. Wang HE, Griffin R, Judd S, Shapiro NI, Safford MM. Obesity and risk of sepsis: a population-based cohort study. Obesity (Silver Spring). 2013;21(12):E762–E9.
6.
Zurück zum Zitat Sakr Y, Moreira CL, Rhodes A, Ferguson ND, Kleinpell R, Pickkers P, et al. The impact of hospital and ICU organizational factors on outcome in critically ill patients: results from the extended prevalence of infection in intensive care study. Crit Care Med. 2015;43(3):519–26.PubMed Sakr Y, Moreira CL, Rhodes A, Ferguson ND, Kleinpell R, Pickkers P, et al. The impact of hospital and ICU organizational factors on outcome in critically ill patients: results from the extended prevalence of infection in intensive care study. Crit Care Med. 2015;43(3):519–26.PubMed
7.
Zurück zum Zitat Wernly B, Heramvand N, Masyuk M, Rezar R, Bruno RR, Kelm M, et al. Acidosis predicts mortality independently from hyperlactatemia in patients with sepsis. Eur J Intern Med. 2020;76:76–81.PubMed Wernly B, Heramvand N, Masyuk M, Rezar R, Bruno RR, Kelm M, et al. Acidosis predicts mortality independently from hyperlactatemia in patients with sepsis. Eur J Intern Med. 2020;76:76–81.PubMed
8.
Zurück zum Zitat Wernly B, Bruno RR, Kelm M, Boumendil A, Morandi A, Andersen FH, et al. Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis. Sci Rep. 2020;10(1):18671.PubMedPubMedCentral Wernly B, Bruno RR, Kelm M, Boumendil A, Morandi A, Andersen FH, et al. Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis. Sci Rep. 2020;10(1):18671.PubMedPubMedCentral
9.
Zurück zum Zitat Wernly B, Bruno RR, Mamandipoor B, Jung C, Osmani V. Sex-specific outcomes and management in critically ill septic patients. Eur J Intern Med. 2020;83:74–77.PubMed Wernly B, Bruno RR, Mamandipoor B, Jung C, Osmani V. Sex-specific outcomes and management in critically ill septic patients. Eur J Intern Med. 2020;83:74–77.PubMed
10.
Zurück zum Zitat Wernly B, Mamandipoor B, Baldia P, Jung C, Osmani V. Machine learning predicts mortality in septic patients using only routinely available ABG variables: a multi-centre evaluation. Int J Med Inform. 2020;145:104312.PubMed Wernly B, Mamandipoor B, Baldia P, Jung C, Osmani V. Machine learning predicts mortality in septic patients using only routinely available ABG variables: a multi-centre evaluation. Int J Med Inform. 2020;145:104312.PubMed
11.
Zurück zum Zitat Moss SR, Prescott HC. Current controversies in sepsis management. Semin Respir Crit Care Med. 2019;40(5):594–603.PubMed Moss SR, Prescott HC. Current controversies in sepsis management. Semin Respir Crit Care Med. 2019;40(5):594–603.PubMed
12.
Zurück zum Zitat Vincent JL, Marshall JC, Namendys-Silva SA, Francois B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380–6.PubMed Vincent JL, Marshall JC, Namendys-Silva SA, Francois B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380–6.PubMed
13.
Zurück zum Zitat van Vught LA, Klein Klouwenberg PM, Spitoni C, Scicluna BP, Wiewel MA, Horn J, et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315(14):1469–79.PubMed van Vught LA, Klein Klouwenberg PM, Spitoni C, Scicluna BP, Wiewel MA, Horn J, et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315(14):1469–79.PubMed
16.
Zurück zum Zitat Lee SM, Kang JW, Jo YH, Kim K, Lee JH, Lee J, et al. Underweight is associated with mortality in patients with severe sepsis and septic shock. Intensive Care Med Exp. 2015;3(1):A876.PubMedCentral Lee SM, Kang JW, Jo YH, Kim K, Lee JH, Lee J, et al. Underweight is associated with mortality in patients with severe sepsis and septic shock. Intensive Care Med Exp. 2015;3(1):A876.PubMedCentral
17.
Zurück zum Zitat Zhou Q, Wang M, Li S, Zhang J, Ma Q, Ding Y, et al. Impact of body mass index on survival of medical patients with sepsis: a prospective cohort study in a university hospital in China. BMJ Open. 2018;8(9):e21979.PubMedPubMedCentral Zhou Q, Wang M, Li S, Zhang J, Ma Q, Ding Y, et al. Impact of body mass index on survival of medical patients with sepsis: a prospective cohort study in a university hospital in China. BMJ Open. 2018;8(9):e21979.PubMedPubMedCentral
18.
Zurück zum Zitat Trivedi V, Bavishi C, Jean R. Impact of obesity on sepsis mortality: a systematic review. J Crit Care. 2015;30(3):518–24.PubMed Trivedi V, Bavishi C, Jean R. Impact of obesity on sepsis mortality: a systematic review. J Crit Care. 2015;30(3):518–24.PubMed
19.
Zurück zum Zitat Prescott HC, Chang VW, O’Brien JM Jr., Langa KM, Iwashyna TJ. Obesity and 1‑year outcomes in older Americans with severe sepsis. Crit Care Med. 2014;42(8):1766–74.PubMedPubMedCentral Prescott HC, Chang VW, O’Brien JM Jr., Langa KM, Iwashyna TJ. Obesity and 1‑year outcomes in older Americans with severe sepsis. Crit Care Med. 2014;42(8):1766–74.PubMedPubMedCentral
20.
Zurück zum Zitat Hogue CW Jr., Stearns JD, Colantuoni E, Robinson KA, Stierer T, Mitter N, et al. The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med. 2009;35(7):1152–70.PubMed Hogue CW Jr., Stearns JD, Colantuoni E, Robinson KA, Stierer T, Mitter N, et al. The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med. 2009;35(7):1152–70.PubMed
21.
Zurück zum Zitat Pepper DJ, Demirkale CY, Sun J, Rhee C, Fram D, Eichacker P, et al. Does obesity protect against death in sepsis? A retrospective cohort study of 55,038 adult patients. Crit Care Med. 2019;47(5):643–50.PubMedPubMedCentral Pepper DJ, Demirkale CY, Sun J, Rhee C, Fram D, Eichacker P, et al. Does obesity protect against death in sepsis? A retrospective cohort study of 55,038 adult patients. Crit Care Med. 2019;47(5):643–50.PubMedPubMedCentral
22.
Zurück zum Zitat Amundson DE, Djurkovic S, Matwiyoff GN. The obesity paradox. Crit Care Clin. 2010;26(4):583–96.PubMed Amundson DE, Djurkovic S, Matwiyoff GN. The obesity paradox. Crit Care Clin. 2010;26(4):583–96.PubMed
23.
Zurück zum Zitat Pollard TJ, Johnson AEW, Raffa JD, Celi LA, Mark RG, Badawi O. The eICU Collaborative Research Database, a freely available multi-center database for critical care research. Sci Data. 2018;5:180178.PubMedPubMedCentral Pollard TJ, Johnson AEW, Raffa JD, Celi LA, Mark RG, Badawi O. The eICU Collaborative Research Database, a freely available multi-center database for critical care research. Sci Data. 2018;5:180178.PubMedPubMedCentral
24.
Zurück zum Zitat Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.PubMed Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.PubMed
26.
Zurück zum Zitat Li S, Hu X, Xu J, Huang F, Guo Z, Tong L, et al. Increased body mass index linked to greater short- and long-term survival in sepsis patients: a retrospective analysis of a large clinical database. Int J Infect Dis. 2019;87:109–16.PubMed Li S, Hu X, Xu J, Huang F, Guo Z, Tong L, et al. Increased body mass index linked to greater short- and long-term survival in sepsis patients: a retrospective analysis of a large clinical database. Int J Infect Dis. 2019;87:109–16.PubMed
27.
Zurück zum Zitat Wang S, Liu X, Chen Q, Liu C, Huang C, Fang X. The role of increased body mass index in outcomes of sepsis: a systematic review and meta-analysis. BMC Anesthesiol. 2017;17(1):118.PubMedPubMedCentral Wang S, Liu X, Chen Q, Liu C, Huang C, Fang X. The role of increased body mass index in outcomes of sepsis: a systematic review and meta-analysis. BMC Anesthesiol. 2017;17(1):118.PubMedPubMedCentral
28.
Zurück zum Zitat Niedziela J, Hudzik B, Niedziela N, Gasior M, Gierlotka M, Wasilewski J, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29(11):801–12.PubMedPubMedCentral Niedziela J, Hudzik B, Niedziela N, Gasior M, Gierlotka M, Wasilewski J, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29(11):801–12.PubMedPubMedCentral
29.
Zurück zum Zitat Ni YN, Luo J, Yu H, Wang YW, Hu YH, Liu D, et al. Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis. Crit Care. 2017;21(1):36.PubMedPubMedCentral Ni YN, Luo J, Yu H, Wang YW, Hu YH, Liu D, et al. Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis. Crit Care. 2017;21(1):36.PubMedPubMedCentral
30.
Zurück zum Zitat Jagan N, Morrow LE, Walters RW, Plambeck RW, Wallen TJ, Patel TM, et al. Sepsis and the obesity paradox: size matters in more than one way. Crit Care Med. 2020;48(9):e776–e82.PubMed Jagan N, Morrow LE, Walters RW, Plambeck RW, Wallen TJ, Patel TM, et al. Sepsis and the obesity paradox: size matters in more than one way. Crit Care Med. 2020;48(9):e776–e82.PubMed
31.
Zurück zum Zitat Zampieri FG, Jacob V, Barbeiro HV, Pinheiro da Silva F, de Souza HP. Influence of body mass index on inflammatory profile at admission in critically ill septic patients. Int J Inflam. 2015;2015:734857.PubMedPubMedCentral Zampieri FG, Jacob V, Barbeiro HV, Pinheiro da Silva F, de Souza HP. Influence of body mass index on inflammatory profile at admission in critically ill septic patients. Int J Inflam. 2015;2015:734857.PubMedPubMedCentral
32.
Zurück zum Zitat Shimada T, Topchiy E, Leung AKK, Kong HJ, Genga KR, Boyd JH, et al. Very low density lipoprotein receptor sequesters lipopolysaccharide into adipose tissue during sepsis. Crit Care Med. 2020;48(1):41–8.PubMed Shimada T, Topchiy E, Leung AKK, Kong HJ, Genga KR, Boyd JH, et al. Very low density lipoprotein receptor sequesters lipopolysaccharide into adipose tissue during sepsis. Crit Care Med. 2020;48(1):41–8.PubMed
33.
Zurück zum Zitat Walley KR, Thain KR, Russell JA, Reilly MP, Meyer NJ, Ferguson JF, et al. PCSK9 is a critical regulator of the innate immune response and septic shock outcome. Sci Transl Med. 2014;6(258):258ra143.PubMedPubMedCentral Walley KR, Thain KR, Russell JA, Reilly MP, Meyer NJ, Ferguson JF, et al. PCSK9 is a critical regulator of the innate immune response and septic shock outcome. Sci Transl Med. 2014;6(258):258ra143.PubMedPubMedCentral
34.
Zurück zum Zitat van Eijk LT, van der Pluijm RW, Ramakers BP, Dorresteijn MJ, van der Hoeven JG, Kox M, et al. Body mass index is not associated with cytokine induction during experimental human endotoxemia. Innate Immun. 2014;20(1):61–7.PubMed van Eijk LT, van der Pluijm RW, Ramakers BP, Dorresteijn MJ, van der Hoeven JG, Kox M, et al. Body mass index is not associated with cytokine induction during experimental human endotoxemia. Innate Immun. 2014;20(1):61–7.PubMed
35.
Zurück zum Zitat Xu W, Pepper D, Sun J, Welsh J, Cui X, Eichacker PQ. The effects of obesity on outcome in preclinical animal models of infection and sepsis: a systematic review and meta-analysis. J Obes. 2020;2020:1508764.PubMedPubMedCentral Xu W, Pepper D, Sun J, Welsh J, Cui X, Eichacker PQ. The effects of obesity on outcome in preclinical animal models of infection and sepsis: a systematic review and meta-analysis. J Obes. 2020;2020:1508764.PubMedPubMedCentral
37.
Zurück zum Zitat Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548–56. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548–56.
38.
Zurück zum Zitat Arabi YM, Dara SI, Tamim HM, Rishu AH, Bouchama A, Khedr MK, et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care. 2013;17(2):R72.PubMedPubMedCentral Arabi YM, Dara SI, Tamim HM, Rishu AH, Bouchama A, Khedr MK, et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care. 2013;17(2):R72.PubMedPubMedCentral
39.
Zurück zum Zitat Guidet B, de Lange DW, Boumendil A, Leaver S, Watson X, Boulanger C, et al. The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study. Intensive Care Med. 2020;46(1):57–69.PubMed Guidet B, de Lange DW, Boumendil A, Leaver S, Watson X, Boulanger C, et al. The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study. Intensive Care Med. 2020;46(1):57–69.PubMed
40.
Zurück zum Zitat Flaatten H, De Lange DW, Morandi A, Andersen FH, Artigas A, Bertolini G, et al. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years). Intensive Care Med. 2017;43(12):1820–8.PubMed Flaatten H, De Lange DW, Morandi A, Andersen FH, Artigas A, Bertolini G, et al. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years). Intensive Care Med. 2017;43(12):1820–8.PubMed
41.
Zurück zum Zitat Weng L, Fan J, Yu C, Guo Y, Bian Z, Wei Y, et al. Body-mass index and long-term risk of sepsis-related mortality: a population-based cohort study of 0.5 million Chinese adults. Crit Care. 2020;24(1):534.PubMedPubMedCentral Weng L, Fan J, Yu C, Guo Y, Bian Z, Wei Y, et al. Body-mass index and long-term risk of sepsis-related mortality: a population-based cohort study of 0.5 million Chinese adults. Crit Care. 2020;24(1):534.PubMedPubMedCentral
42.
Zurück zum Zitat Kalbacher D, Tigges E, Boekstegers P, Puls M, Plicht B, Eggebrecht H, et al. Underweight is associated with inferior short and long-term outcomes after MitraClip implantation: results from the German TRAnscatheter mitral valve interventions (TRAMI) registry. Am Heart J. 2020;222:73–82.PubMed Kalbacher D, Tigges E, Boekstegers P, Puls M, Plicht B, Eggebrecht H, et al. Underweight is associated with inferior short and long-term outcomes after MitraClip implantation: results from the German TRAnscatheter mitral valve interventions (TRAMI) registry. Am Heart J. 2020;222:73–82.PubMed
43.
Zurück zum Zitat Little M, Humphries S, Patel K, Dewey C. Factors associated with BMI, underweight, overweight, and obesity among adults in a population of rural south India: a cross-sectional study. BMC Obes. 2016;3:12.PubMedPubMedCentral Little M, Humphries S, Patel K, Dewey C. Factors associated with BMI, underweight, overweight, and obesity among adults in a population of rural south India: a cross-sectional study. BMC Obes. 2016;3:12.PubMedPubMedCentral
44.
Zurück zum Zitat Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser comorbidity index. Med Care. 2017;55(7):698–705.PubMed Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser comorbidity index. Med Care. 2017;55(7):698–705.PubMed
45.
Zurück zum Zitat Oami T, Karasawa S, Shimada T, Nakada TA, Abe T, Ogura H, et al. Association between low body mass index and increased 28-day mortality of severe sepsis in Japanese cohorts. Sci Rep. 2021;11(1):1615.PubMedPubMedCentral Oami T, Karasawa S, Shimada T, Nakada TA, Abe T, Ogura H, et al. Association between low body mass index and increased 28-day mortality of severe sepsis in Japanese cohorts. Sci Rep. 2021;11(1):1615.PubMedPubMedCentral
46.
Zurück zum Zitat Bahat G, Tufan F, Saka B, Akin S, Ozkaya H, Yucel N, et al. Which body mass index (BMI) is better in the elderly for functional status? Arch Gerontol Geriatr. 2012;54(1):78–81.PubMed Bahat G, Tufan F, Saka B, Akin S, Ozkaya H, Yucel N, et al. Which body mass index (BMI) is better in the elderly for functional status? Arch Gerontol Geriatr. 2012;54(1):78–81.PubMed
47.
Zurück zum Zitat Marques A, Peralta M, Naia A, Loureiro N, de Matos MG. Prevalence of adult overweight and obesity in 20 European countries, 2014. Eur J Public Health. 2018;28(2):295–300.PubMed Marques A, Peralta M, Naia A, Loureiro N, de Matos MG. Prevalence of adult overweight and obesity in 20 European countries, 2014. Eur J Public Health. 2018;28(2):295–300.PubMed
48.
Zurück zum Zitat Marik PE, Byrne L, van Haren F. Fluid resuscitation in sepsis: the great 30 mL per kg hoax. J Thorac Dis. 2020;12(S1):S37–S47.PubMedPubMedCentral Marik PE, Byrne L, van Haren F. Fluid resuscitation in sepsis: the great 30 mL per kg hoax. J Thorac Dis. 2020;12(S1):S37–S47.PubMedPubMedCentral
Metadaten
Titel
Underweight but not overweight is associated with excess mortality in septic ICU patients
verfasst von
Thomas Danninger, M.D.
Richard Rezar, M.D.
Behrooz Mamandipoor, M.Sc.
Daniel Dankl, M.D.
Andreas Koköfer, M.D.
Christian Jung, M.D., Ph.D.
Bernhard Wernly, M.D., Ph.D.
Venet Osmani, Ph.D.
Publikationsdatum
16.09.2021
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2022
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-021-01912-0

Weitere Artikel der Ausgabe 3-4/2022

Wiener klinische Wochenschrift 3-4/2022 Zur Ausgabe